Literature DB >> 3875317

Histiocytosis X--current controversies.

V Broadbent, J Pritchard.   

Abstract

Mesh：

Year:  1985        PMID： 3875317      PMCID： PMC1777288          DOI： 10.1136/adc.60.7.605

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

Review 1.  The suppressor-cell network in cancer (first of two parts).

Authors:  S Broder; T A Waldmann
Journal:  N Engl J Med       Date:  1978-12-07       Impact factor: 91.245

2.  Histiocytosis X--comparison of three treatment regimens.

Authors:  M E Lahey
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

3.  The course and prognosis of reticuloendotheliosis (eosinophilic granuloma, Schüller-Christian disease and Letterer-Siwe disease); a study of forty cases.

Authors:  M E AVERY; J G MCAFEE; H G GUILD
Journal:  Am J Med       Date:  1957-04       Impact factor: 4.965

4.  Histiocytosis X: natural history and management in childhood.

Authors:  J Pritchard
Journal:  Clin Exp Dermatol       Date:  1979-12       Impact factor: 3.470

5.  Histiocytosis X; follow-up of 43 cases.

Authors:  D G Sims
Journal:  Arch Dis Child       Date:  1977-06       Impact factor: 3.791

6.  A staging system for histiocytosis X: a Southwest Oncology Group Study.

Authors:  D M Komp; J Herson; K A Starling; T J Vietti; E Hvizdala
Journal:  Cancer       Date:  1981-02-15       Impact factor: 6.860

7.  Quality of survival in histiocytosis X: a Southwest Oncology Group study.

Authors:  D M Komp; A El Mahdi; K A Starling; J Easley; T J Vietti; D H Berry; S L George
Journal:  Med Pediatr Oncol       Date:  1980

Review 8.  The histiocytic disorders: a pathophysiologic analysis.

Authors:  J E Groopman; D W Golde
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

9.  Combination chemotherapy in histiocytosis X.

Authors:  D M Komp; T J Vietti; D H Berry; K A Starling; M E Haggard; S L George
Journal:  Med Pediatr Oncol       Date:  1977

10.  Histiocytosis-X.

Authors:  M E Osband; J M Lipton; P Lavin; R Levey; G Vawter; J S Greenberger; R P McCaffrey; R Parkman
Journal:  N Engl J Med       Date:  1981-01-15       Impact factor: 91.245
View more
  10 in total

1.  Histiocytosis X: response to chemotherapy.

Authors:  J McLelland; V Broadbent
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

2.  HEAD AND NECK TUMOURS IN CHILDREN - A REPORT ON THREE CASES.

Authors:  A Ravikumar; R Chattopadhyaya
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Globe luxation in histiocytosis X.

Authors:  C M Wood; A D Pearson; A W Craft; J W Howe
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

4.  Favourable prognostic features in histiocytosis X: bone involvement and absence of skin disease.

Authors:  V Broadbent
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

5.  Langerhans cell histiocytosis--clinical and epidemiological aspects.

Authors:  V Broadbent; R M Egeler; M E Nesbit
Journal:  Br J Cancer Suppl       Date:  1994-09

6.  Langerhans cell histiocytosis--a 31 year review.

Authors:  P Leavey; M Varughese; F Breatnach; A O'Meara
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

7.  Langerhans cell histiocytosis: the case for conservative treatment.

Authors:  J McLelland; V Broadbent; E Yeomans; M Malone; J Pritchard
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

Review 8.  Treatment of Langerhans cell histiocytosis--evolution and current approaches.

Authors:  S Ladisch; H Gadner
Journal:  Br J Cancer Suppl       Date:  1994-09

9.  [A painful hip bone revealing multifocal histiocytosis].

Authors:  Kamal Lahrach; Adil Alaoui; Khalid Ibn el Kadi; Amine Marzouki; Fawzi Boutayeb
Journal:  Pan Afr Med J       Date:  2014-02-12

10.  Spontaneous remission of eosinophilic granuloma of the maxilla after incisional biopsy: a case report.

Authors:  Alex Vargas; Hernán Ramírez; Pablo Ramírez; Camila Foncea; Bernardo Venegas; Paula Astorga
Journal:  Head Face Med       Date:  2016-06-02       Impact factor: 2.151
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.